Daily non-political popular news in brief.
New saliva test may help dentists test for breast cancer
03-20-2007 · EurekAlert!Breast cancer is the second leading cause of death among women in the United States. Many women's lives could be saved if this cancer was diagnosed earlier, and early diagnosis could be achieved if there were more and easier opportunities to do so. Researchers found that salivary testing could help dentists test for breast cancer.
Read more »
Keywords: saliva, test, dentists, breast, cancer, dentist
« Previous | Next »
Similar news on "New saliva test may help dentists test for breast cancer":
- UT Health Science Center researchers decoding saliva to detect breast cancer
01-10-2008 · EurekAlert!
Researchers at The University of Texas Health Science Center at Houston can identify and quantify specific protein markers in human saliva to provide an early, non-invasive diagnosis of breast cancer, according to a study appearing today in the journal Cancer Investigation. The study is being applied to "lab-on-a-chip" technology that may bring this type of diagnostic test -- capable of detecting the presence of cancer before a tumor forms -- into everyday use.
Similar news · Read more »
- New study suggests Concord grape juice may provide protection against breast cancer
08-09-2007 · EurekAlert!
According to a new study, published in the current issue of the Journal of Medicinal Foods, natural compounds in Concord grape juice protected healthy human breast cells from DNA damage. Healthy human breast cells were exposed in a test tube to an environmental carcinogen, benzo(a)pyrene, that is able to initiate a chain of events leading to breast cancer. However, the introduction of Concord grape juice compounds blocked the connection of the carcinogen to the DNA of the healthy cells.
Similar news · Read more »
- Genesearch Breast Lymph Node assay detects breast cancer metastases with greater sensitivity
12-16-2006 · EurekAlert!
Results from a prospective clinical study show that the GeneSearch™ Breast Lymph Node (BLN) Assay, a gene-based diagnostic test has greater sensitivity than traditional intra-operative methods of detecting the spread of breast cancer to the lymph nodes. In the study sponsored by Veridex, LLC, the GeneSearch™ BLN Assay demonstrated overall sensitivity at least 10 percentage points higher than traditional intra-operative tests. The data were presented today at the 29th annual San Antonio Breast Cancer Symposium.
Similar news · Read more »
- Gene expression test reveals ER and HER-2 status of breast tumors
02-14-2007 · EurekAlert!
Two critical characteristics of breast cancer that are important to treatment can be identified by measuring gene expression in the tumor, a research team led by scientists at the University of Texas M. D. Anderson Cancer Center reports in Lancet Oncology online.
Similar news · Read more »
- UM researchers find new marker to identify cancer stem cells
12-03-2007 · EurekAlert!
Researchers at the University of Michigan Comprehensive Cancer Center have found a marker that can be used to identify stem cells in breast tumors, suggesting a potential simple test that could help determine the best treatment for breast cancer.
Similar news · Read more »
- Uninsured, others less likely to receive breast cancer test
12-03-2007 · EurekAlert!
An American Cancer Society study finds breast cancer patients who lack insurance, who come from areas with lower education levels, who are African-American, or who are older are less likely to get a key diagnostic test to make appropriate treatment decisions.
Similar news · Read more »
- World first test potential to identify breast cancer patients who will react badly to radiotherapy
04-19-2007 · EurekAlert!
Medical scientists at the University of Leicester have announced a potentially unique advance in breast cancer research by identifying two genes associated with adverse reaction to cancer treatment.
Similar news · Read more »
- Mouse Tests Predict Drug Response In Relapsing Pancreatic Cancer Patients
10-12-2006 · ScienceDaily
By slicing up bits of patient tumors and grafting them into mice, Johns Hopkins Kimmel Cancer Center specialists have figured out how to accurately 'test drive' chemotherapy drugs to learn in advance which drug treatments offer each individual pancreatic cancer patient the best therapeutic journey.
Similar news · Read more »
- Preventing graft-vs.-host disease after bone marrow transplant -- without toxicity
12-11-2006 · EurekAlert!
Most patients undergoing bone-marrow transplant must receive powerful chemotherapy drugs to suppress their immune system and prevent their bodies from rejecting the donated cells. New research shows that this chemotherapy increases the risk for graft-versus-host disease -- but also suggests that this risk can be reduced by replacing a natural antibiotic that's depleted when patients undergo chemotherapy. A multicenter study led by Children's Hospital Boston and the Dana-Farber Cancer Institute is about to test this idea.
Similar news · Read more »
- Calculated risk
01-24-2007 · EurekAlert!
A simple blood test may be able to identify those most at risk for developing head and neck cancer as a result of smoking.
Similar news · Read more »